Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
Launch innovative vitamin sublingual sprays
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
Seen in 1 in 3 million births, the malformation was detected at the antenatal stage during the mother's pregnancy
Subscribe To Our Newsletter & Stay Updated
